PatternsRadar
Sign in

THEMISMEDThemis Medicare Limited

NSE
94.87INR-2.11 (-2.18%)Close · 20 Nov 2026
14 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹874 CrMarket cap
17.3P/E (TTM)
64.2%Delivery

Filings & corporate actions

77 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 14 Feb 2027
Estimate: filed 34–45 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 23 Sept 2026
2026
  • 14 NovresultsResults · Q2 FY27 · consolidated and standalone-5.9%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-5.6%NSE
  • 23 SeptdividendDividend · ₹0.50 per share · record 23 Sept 2026-0.5%
  • 13 AugresultsResults · Q1 FY27 · consolidated and standalone-4.3%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-0.8%NSE
  • 28 MayresultsResults · Q4 FY26 · consolidated and standalone-3.8%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.9%NSE
  • 13 FebresultsResults · Q3 FY26 · consolidated and standalone+0.3%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025+0.3%NSE

Reaction to results · all yearsrose on day 0 in 27 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2714 Nov 2026-5.9%——1.6×
Q1 FY2713 Aug 2026-4.3%-5.4%+21.6%9.0×
Q4 FY2628 May 2026-3.8%-8.4%-1.2%1.4×
Q3 FY2613 Feb 2026+0.3%-1.7%-17.1%0.9×
Q2 FY2613 Nov 2025-3.8%-8.8%-16.2%1.8×
Q1 FY261 Aug 2025-2.5%+2.2%-2.0%1.1×
Q4 FY2520 May 2025-11.1%-13.6%-16.4%3.9×
Q3 FY2514 Feb 2025-3.3%-9.0%-17.2%1.0×
Q2 FY2525 Oct 2024-1.3%-0.6%+8.3%1.0×
Q1 FY2526 Jul 2024+3.7%-5.5%+4.0%4.2×
Q4 FY2414 May 2024-1.6%-1.4%+5.5%1.3×
Q3 FY2410 Feb 2024-7.6%+12.3%+9.8%2.2×
Q2 FY244 Nov 2023-8.8%+5.5%+14.1%3.6×
Q1 FY2410 Aug 2023+6.5%+4.9%+4.2%4.3×
Q4 FY2313 May 2023-0.4%+0.2%-7.1%1.7×
Q3 FY233 Feb 2023-1.9%+6.9%-1.5%1.2×
Q2 FY238 Nov 2022-0.1%-0.8%+18.5%2.9×
Q1 FY2328 Jul 2022-3.3%+1.1%+2.9%1.8×
Q4 FY2221 May 2022-5.2%-10.4%-20.2%1.3×
Q3 FY2211 Feb 2022-2.2%-2.0%-7.8%1.3×
Q1 FY2213 Aug 2021-1.8%-3.0%-4.8%1.9×
Q4 FY2128 May 2021+6.9%+50.0%+31.9%0.6×
Q3 FY2113 Feb 2021-5.8%-11.7%-14.8%5.5×
Q2 FY2113 Nov 2020+6.5%-1.3%+9.2%3.4×
Q1 FY2115 Aug 2020-1.1%-1.6%-27.1%1.6×
Q4 FY209 Jun 2020-7.5%-11.0%+2.4%4.7×
Q3 FY207 Feb 2020+5.0%+10.5%-16.6%0.4×
Q2 FY2014 Nov 2019-5.1%-18.0%-17.5%0.3×
Q1 FY207 Aug 2019+4.9%+12.3%+11.0%0.0×
Q4 FY1928 May 2019+5.2%+3.6%-11.8%6.3×
Q3 FY1913 Feb 2019-0.9%+2.3%+4.0%1.1×
Q2 FY1922 Nov 20180.0%-6.4%-13.3%0.4×
Q1 FY1928 Aug 2018+1.8%+1.2%-2.2%1.2×
Q4 FY1821 Jun 2018-2.7%-10.3%-23.6%0.8×
Q3 FY1815 Feb 2018-6.1%-9.0%+0.4%0.6×
Q2 FY1818 Dec 2017-1.5%+1.5%+5.0%0.3×
Q1 FY187 Sept 2017+1.7%+0.2%+4.2%0.3×
Q4 FY1713 Jun 2017+0.3%-1.3%-0.4%0.6×
Q3 FY1715 Feb 2017-0.4%+5.3%+1.7%0.9×
Q2 FY179 Nov 2016-1.5%-10.2%-4.9%0.8×
Q1 FY1712 Aug 2016-2.4%+7.7%+9.9%1.2×
Q4 FY1618 May 2016-1.2%+0.4%+12.7%0.6×
Q3 FY1613 Feb 2016+2.4%-2.9%+19.4%1.2×
Q2 FY167 Nov 2015+4.9%+29.7%+44.7%1.6×
Q1 FY1614 Aug 2015-1.7%0.0%-1.7%1.2×
Q4 FY1528 May 20150.0%-0.8%+15.8%0.9×
Q3 FY1510 Feb 2015+4.3%-2.1%-12.3%0.0×
Q2 FY1510 Nov 2014-2.9%+8.6%+50.0%3.1×
Q1 FY1512 Aug 2014-4.0%+6.2%+23.5%0.8×
Q4 FY1415 May 2014-1.5%+14.7%+27.9%10.8×
Q3 FY1418 Feb 2014+4.6%+5.6%+11.1%0.2×
Q2 FY1415 Nov 2013+1.9%-4.8%+13.5%0.7×
Q1 FY1412 Aug 2013-4.5%-9.1%-6.8%0.2×
Q4 FY1318 May 2013-4.3%-5.0%-18.7%0.2×
Q3 FY135 Feb 2013-5.9%-20.4%-21.7%1.4×
Q2 FY1310 Nov 2012+3.5%-7.1%-15.0%1.7×
Q1 FY1331 Jul 2012+6.3%+5.0%+16.3%0.7×
Q4 FY1214 May 2012-5.3%-7.6%-7.6%0.5×
Q3 FY121 Feb 2012-2.2%+3.4%+5.6%1.7×
Q2 FY124 Nov 2011+0.9%-23.7%-36.0%0.0×
Q1 FY121 Aug 2011-5.2%-7.2%-22.5%0.9×
Q4 FY1124 Jun 2011+1.9%0.0%-5.7%0.0×
Q3 FY1131 Jan 2011-8.5%-11.0%-18.8%2.1×
Q2 FY1111 Nov 2010-3.9%-6.4%-12.1%0.5×
Q1 FY1131 Jul 2010-1.4%-1.4%-5.1%0.3×
Q4 FY1027 Apr 2010+2.4%-6.9%-18.8%1.0×
Q3 FY1029 Jan 2010+6.1%+9.1%+15.2%0.2×
Q2 FY1030 Oct 2009-4.0%+7.4%-1.3%0.4×
Q4 FY0931 Jul 2009+9.9%+24.8%+87.2%2.2×
Q1 FY1031 Jul 2009+9.9%+24.8%+87.2%2.2×
Q3 FY0930 Jan 2009-5.0%-5.0%-20.9%0.1×
Q2 FY0927 Oct 2008+2.8%+9.9%+9.9%4.0×
Q1 FY0931 Jul 2008-9.4%+7.1%+3.9%0.6×
Q4 FY0818 Jun 2008+3.6%-9.6%-17.5%0.8×
Q3 FY0819 Jan 2008-8.8%-15.7%+0.4%0.9×
Q2 FY0822 Oct 2007-4.0%+4.3%+7.7%0.0×
Q1 FY0818 Jul 2007+3.1%-6.1%-16.9%0.3×
Q4 FY0729 Jun 2007-4.6%+7.2%-8.4%0.5×
Average-1.0%-0.1%+1.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+15.1%
Profit YoY—
Interest cost YoY+0.6%
Revenue QoQ+3.2%
Profit QoQ-71.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-9.6%-2.5%-1.2%—+9.1%—
Profit-2.2%-0.3%-8.3%—+7.0%—

Key data

Open97.00
Day range94.05 – 97.70
52-week range64.95 – 140.60
From 52w high-32.5%
RSI (14)37.3
ATR (14)4.79
Volume13.9K
Avg volume (20D)41.3K
Rel volume0.34×
Volatility (1Y)52.1%
Turnover₹13.2L
Traded value (NSE)₹13.2L
VWAP95.39
SMA 50 / 200107.82 / 101.55
Price band20%

Delivery percentage

Latest · 20 Nov 202664.2%
20-day avg51.3%
1-year avg50.5%
Percentile (own history)49th
Range0.0–100.0%
Sessions3,033

Over the last 20 sessions THEMISMED settled 51.3% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.5%. The latest session ranks higher than 49% of the 3,033 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.53%
Dividend, trailing 12M₹0.50
Paid every year for7 yr
Shareholders20.1K · -5.4% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy407 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.18%-5.98%+0.30%-7.69%-3.82%-18.89%

Valuation

Market cap₹874 Cr
Market cap (NSE)₹874 Cr
Free-float cap₹287 Cr
P/E (TTM)17.3
P/E (NSE)17.6
EPS (TTM)5.50
P/B2.1
Net margin (TTM)14.8%
Other income / PBT21.0%
ROE12.6%
Debt / equity0.18
Shares outstanding9.21Cr
Listed2 Apr 2007

Ownership

Promoter67.11%
Promoter Δ QoQ0.00 pp
Public32.89%
FII0.01%
DII0.01%
Pledged45.82%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)90.176.587.089.7
YoY chg-3.9%+6.7%-10.9%+15.1%
Net profit (₹ Cr)10.18.924.67.1
YoY chg+1843.7%———
Net margin11.2%11.6%28.3%7.9%
EPS1.090.962.670.77

Shareholding over time

By quarter

30 Sept 2026 · promoter 67.11% · public 32.89%
30 Sept 2021: promoter 67.18%31 Dec 2021: promoter 67.18%31 Mar 2022: promoter 67.18%30 Jun 2022: promoter 67.18%30 Sept 2022: promoter 67.18%31 Dec 2022: promoter 67.18%31 Mar 2023: promoter 67.16%30 Jun 2023: promoter 67.16%30 Sept 2023: promoter 67.16%31 Dec 2023: promoter 67.16%31 Mar 2024: promoter 67.15%30 Jun 2024: promoter 67.15%30 Sept 2024: promoter 67.15%31 Dec 2024: promoter 67.15%31 Mar 2025: promoter 67.15%30 Jun 2025: promoter 67.15%30 Sept 2025: promoter 67.15%31 Dec 2025: promoter 67.11%31 Mar 2026: promoter 67.11%30 Jun 2026: promoter 67.11%30 Sept 2026: promoter 67.11%
2021-092026-09
  • Promoter
  • Public and others
Promoter
67.11%
Public
32.89%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
0.01%
DII
0.01%
Promoter pledged
45.82%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.01%

0.00 pp QoQ

Retail ≤ ₹2L
16.43%

-0.72 pp QoQ

HNI > ₹2L
6.83%

+0.41 pp QoQ

NRI
3.06%

-0.02 pp QoQ

Bodies corporate
4.16%

+0.47 pp QoQ

Shareholders
20,126

-5.4% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
DINESH SHANTILAL PATEL, JAYSHREE DINESH PATEL, SACHIN DINESH PATEL (TRUSTEES OF VIVIDHMARGI TRUST)Promoter · Individual27.49%
VIVIDHMARGI INVESTMENTS PVTPromoter · Corporate26.52%
GEDEON RICHTER INVESTMENT MANAGEMENT LTD.Promoter · Corporate9.60%
ANUJ ANANTRAI SHETHIndividual3.80%
ZAFAR AHMADULLAHIndividual2.11%
ZA CAPITAL SERVICES INDIA PRIVATE LTDCorporate1.53%
NYSHA RUPEN CHOKSIPromoter · Individual1.28%
ANAY RUPEN CHOKSIPromoter · Individual1.28%
L7 HITECH PRIVATE LIMITEDCorporate1.08%
SHANTILAL DAHYABHAI PATEL HUFPromoter · Individual0.61%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 17 Sept 2020 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.50₹0.50
FY2025-261₹0.50₹0.50
FY2024-251₹0.50₹0.50
FY2023-241₹5.00₹0.50
FY2022-231₹5.00₹0.50
FY2021-221₹4.30₹0.43
FY2020-211₹1.75₹0.17
Ex-dateRecord dateDeclaredAdjusted
23 Sept 202623 Sept 2026₹0.50₹0.50
4 Sept 2025—₹0.50₹0.50
12 Jul 2024—₹0.50₹0.50
1 Sept 2023—₹5.00₹0.50
8 Sept 2022—₹5.00₹0.50
8 Sept 2021—₹4.30₹0.43
17 Sept 2020—₹1.75₹0.17

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
22
17 open-market of the newest 22
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
4 Jan 2023Prakash NaringrekarOtherSell100₹1.4L1,360.052.8K → 2.7K0.03%-0.00 pp7(2)told 2 Jan 2023
4 Jan 2023Prakash NaringrekarOtherSell200₹2.7L1,352.003.0K → 2.8K0.03%-0.00 pp7(2)told 2 Jan 2023
4 Jan 2023Prakash NaringrekarOtherSell467₹6.2L1,336.183.5K → 3.0K0.03%-0.00 pp7(2)told 2 Jan 2023
4 Jan 2023Prakash NaringrekarOtherSell33₹44,0331,334.333.5K → 3.5K0.04%-0.00 pp7(2)told 2 Jan 2023
2 Jul 2021Prakash NaringrekarOtherSell136₹94,901697.803.6K → 3.5K0.04%-0.00 pp7(3)told 2 Jul 2021
2 Jul 2021Prakash NaringrekarOtherSell100₹70,010700.103.7K → 3.6K0.04%-0.00 pp7(3)told 30 Jun 2021
29 Jun 2021Prakash NaringrekarOtherSell100₹71,545715.453.8K → 3.7K0.04%-0.00 pp7(3)told 29 Jun 2021
24 Jun 2021Prakash NaringrekarOtherSell100₹70,800708.003.9K → 3.8K0.04%-0.00 pp7(3)told 24 Jun 2021
22 Jun 2021Prakash NaringrekarOtherSell100₹71,350713.504.0K → 3.9K0.04%-0.00 pp7(3)told 22 Jun 2021
8 Jun 2021Prakash NaringrekarOtherSell100₹80,840808.404.1K → 4.0K0.04%-0.00 pp7(3)told 7 Jun 2021
6 Jun 2021Prakash NaringrekarOtherSell155₹1.2L795.804.3K → 4.1K0.05%-0.00 pp7(3)told 4 Jun 2021
4 Jun 2021Prakash NaringrekarOtherSell200~₹1.5L761.004.5K → 4.3K0.05%-0.00 pp7(3)told 2 Jun 2021
4 Jun 2021Prakash NaringrekarOtherSell300~₹2.3L761.004.8K → 4.5K0.05%-0.00 pp7(3)told 2 Jun 2021
4 Jun 2021Prakash NaringrekarOtherSell300~₹2.3L761.005.1K → 4.8K0.05%-0.00 pp7(3)told 2 Jun 2021
4 Jun 2021Prakash NaringrekarOtherSell200~₹1.3L634.005.3K → 5.1K0.06%-0.00 pp7(3)told 2 Jun 2021
24 Dec 2019Ms. Avantika Vijay AgarwalRelativeBuy8.9K₹25.1L281.87— → 8.9K0.10%7(2)told 5 Dec 2019
24 Dec 2019Ms. Avantika Vijay AgarwalRelativeBuy99₹27,829281.10— → 990.00%7(2)told 5 Dec 2019

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 9 Oct 2025

CSV
5 of 5 deals
By year
DateDealClientQuantityPriceValue
9 Oct 2025Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED6.86L141.72₹9.7Cr
9 Oct 2025Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED6.86L141.61₹9.7Cr
9 Oct 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.59L141.63₹9.3Cr
9 Oct 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.59L141.32₹9.3Cr
2 Jun 2021Buy · bulkTEJAS TRADEFIN LLP72.0K735.76₹5.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to THEMISMED.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations82.597.8123.0117.093.871.797.678.090.176.587.089.7
Other income0.61.11.01.11.01.61.23.21.33.71.04.1
Total income83.198.9124.0118.194.873.398.881.291.480.288.093.9
Total expenses80.293.798.6104.890.682.5112.786.485.778.1144.988.8
└ Finance costs2.72.22.42.42.82.52.52.82.72.73.02.1
└ Depreciation3.13.12.42.52.52.52.62.62.62.62.52.6
Profit before tax2.85.225.413.44.2(9.2)(13.9)(5.2)4.92.136.05.0
Tax expense0.92.16.73.51.1(1.5)0.20.20.30.214.01.2
Net profit7.46.624.714.30.5(9.7)(14.2)(3.6)10.18.924.67.1
EPS0.800.722.681.550.06-1.05-1.54-0.391.100.962.670.77
Net margin8.93%6.79%20.07%12.22%0.55%-13.48%-14.57%-4.64%11.20%11.61%28.30%7.86%
PBT margin3.45%5.29%20.63%11.43%4.50%-12.85%-14.27%-6.66%5.41%2.78%41.41%5.62%
Tax rate29.88%40.67%26.26%26.19%27.03%———6.04%8.00%38.84%22.95%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 14 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets514.0548.5566.4602.2588.0582.5597.9612.4
Current assets264.5285.1293.2312.1303.9299.0305.0315.7
└ Cash & equivalents12.513.59.99.76.68.14.515.9
└ Other bank balances6.38.99.47.96.34.64.64.6
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables145.0177.6177.9200.7177.1173.4178.1154.9
└ Inventories69.059.670.664.684.376.481.1102.9
Total equity339.4364.1377.7412.0402.6380.0398.6425.3
└ Attributable to owners339.4364.1377.7412.0402.6380.0398.6425.3
└ Non-controlling interest(0.0)(0.0)(0.0)(0.0)(0.0)(0.0)(0.0)(0.0)
└ Share capital9.29.29.29.29.29.29.29.2
Borrowings92.094.695.881.583.095.6100.177.6
└ Current63.566.669.057.664.478.078.256.2
└ Non-current28.428.026.823.918.617.621.921.4
Trade payables40.041.847.353.051.446.850.847.4
Current liabilities139.1149.2154.6158.4156.1173.9166.2148.9
Total liabilities174.5184.3188.8190.2185.4202.5199.3187.1
Net debt73.172.276.563.970.282.890.957.1
Debt / equity0.270.260.250.200.210.250.250.18
Current ratio1.901.911.901.971.951.721.842.12

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow16.116.714.533.034.7(1.5)(3.3)(57.4)
└ Capex(28.7)(10.3)(18.4)(11.5)(15.4)(2.6)(4.9)(2.0)
Free cash flow(12.7)6.4(4.0)21.419.3(4.0)(8.1)(59.4)
Investing cash flow(24.0)(9.8)(15.9)(10.0)(12.2)(0.7)(2.5)99.8
Financing cash flow0.1(5.9)(1.1)(23.2)(25.9)3.73.8(30.9)
└ Dividends paid(4.6)(4.6)(4.6)(4.6)(4.6)(4.6)(4.6)(4.6)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(7.7)0.9(2.6)(0.2)(3.4)1.6(2.0)11.4

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

THEMISMED at a glance

  • THEMISMED closed at ₹94.87 on 20 Nov 2026, -2.18% on the day, -18.9% over one year, 32.5% below its 52-week high of ₹140.6.
  • Delivery was 64.2% of traded quantity on 20 Nov 2026, the 49th percentile of its own 3,033 sessions with a reading (20-session average 51.3%, 1-year average 50.5%).
  • Market capitalisation is ₹874 crore at a trailing P/E of 17.3 (trailing EPS ₹5.5).
  • Q2 FY27 results (consolidated, filed 14 Nov 2026): revenue ₹90 crore (+15.1% year on year), net profit ₹7 crore; the price moved -5.9% on the first session after.
  • Promoters held 67.11% at 30 Sept 2026, unchanged on the previous filing, with 45.82% of promoter shares pledged.
  • Q3 FY27 results are expected between 3 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE083B01024
SeriesEQ
Listed2 Apr 2007
NSE market cap · 17 Nov 2026₹884 Cr
Free-float market cap (NSE)₹286 Cr
Shares outstanding (NSE)9.21Cr
History from2 Apr 2007
Sessions4,645

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.